Cancer screening accuracy determines survival outcomes, yet most centers still apply one-size-fits-all protocols that miss high-risk individuals while over-testing others. Personalized risk assessment transforms screening from population-level guesswork into precision medicine tailored to individual genetics, family history, and exposure patterns. TL;DR Multicancer early detection (MCED) blood tests can identify cancer signals 12-18 months before tumors form, but produce a 25

TL;DR Andhra Pradesh's cancer screening initiative identified 117 malignant cases out of 1,367 suspects, demonstrating the critical importance of systematic screening programs [2] Advanced 3D mammography systems reduce radiation exposure while improving diagnostic accuracy for early breast cancer detection [3] Pi Cancer Care by Dr.Bharat Patodiya combines Europe-trained expertise with personalized risk assessment algorithms to deliver precision screening protocols Comprehensi